Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro.

Ng S, March S, Galstian A, Hanson K, Carvalho T, Mota MM, Bhatia SN.

Dis Model Mech. 2014 Feb;7(2):215-24. doi: 10.1242/dmm.013490. Epub 2013 Nov 28.

PMID:
24291761
2.

Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.

Depinay N, Franetich JF, Grüner AC, Mauduit M, Chavatte JM, Luty AJ, van Gemert GJ, Sauerwein RW, Siksik JM, Hannoun L, Mazier D, Snounou G, Rénia L.

PLoS One. 2011 Mar 4;6(3):e17464. doi: 10.1371/journal.pone.0017464.

PMID:
21394207
3.

Mouse models for pre-erythrocytic-stage malaria.

Rénia L, Belnoue E, Landau I.

Methods Mol Med. 2002;72:41-55. No abstract available.

PMID:
12125137
4.

Susceptibility to Plasmodium liver stage infection is altered by hepatocyte polyploidy.

Austin LS, Kaushansky A, Kappe SH.

Cell Microbiol. 2014 May;16(5):784-95. doi: 10.1111/cmi.12282. Epub 2014 Mar 28.

PMID:
24612025
5.

Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Rénia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D.

Nat Med. 2003 Jan;9(1):93-6. Epub 2002 Dec 16.

PMID:
12483205
6.

A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.

March S, Ng S, Velmurugan S, Galstian A, Shan J, Logan DJ, Carpenter AE, Thomas D, Sim BK, Mota MM, Hoffman SL, Bhatia SN.

Cell Host Microbe. 2013 Jul 17;14(1):104-15. doi: 10.1016/j.chom.2013.06.005.

PMID:
23870318
7.

Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.

van Schaijk BC, Janse CJ, van Gemert GJ, van Dijk MR, Gego A, Franetich JF, van de Vegte-Bolmer M, Yalaoui S, Silvie O, Hoffman SL, Waters AP, Mazier D, Sauerwein RW, Khan SM.

PLoS One. 2008;3(10):e3549. doi: 10.1371/journal.pone.0003549. Epub 2008 Oct 28.

PMID:
18958160
8.

Inhibition of Plasmodium sporozoites infection by targeting the host cell.

Leitao R, Rodriguez A.

Exp Parasitol. 2010 Oct;126(2):273-7. doi: 10.1016/j.exppara.2010.05.012. Epub 2010 May 21.

PMID:
20493847
9.

Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.

Siau A, Silvie O, Franetich JF, Yalaoui S, Marinach C, Hannoun L, van Gemert GJ, Luty AJ, Bischoff E, David PH, Snounou G, Vaquero C, Froissard P, Mazier D.

PLoS Pathog. 2008 Aug 8;4(8):e1000121. doi: 10.1371/journal.ppat.1000121.

PMID:
18688281
10.

Flow Cytometry Based Detection and Isolation of Plasmodium falciparum Liver Stages In Vitro.

Dumoulin PC, Trop SA, Ma J, Zhang H, Sherman MA, Levitskaya J.

PLoS One. 2015 Jun 12;10(6):e0129623. doi: 10.1371/journal.pone.0129623. eCollection 2015.

PMID:
26070149
11.

Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms.

Prado M, Eickel N, De Niz M, Heitmann A, Agop-Nersesian C, Wacker R, Schmuckli-Maurer J, Caldelari R, Janse CJ, Khan SM, May J, Meyer CG, Heussler VT.

Autophagy. 2015;11(9):1561-79. doi: 10.1080/15548627.2015.1067361.

PMID:
26208778
12.

Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.

Ploemen IH, Prudêncio M, Douradinha BG, Ramesar J, Fonager J, van Gemert GJ, Luty AJ, Hermsen CC, Sauerwein RW, Baptista FG, Mota MM, Waters AP, Que I, Lowik CW, Khan SM, Janse CJ, Franke-Fayard BM.

PLoS One. 2009 Nov 18;4(11):e7881. doi: 10.1371/journal.pone.0007881.

PMID:
19924309
13.

In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.

Calvo-Calle JM, Moreno A, Eling WM, Nardin EH.

Exp Parasitol. 1994 Nov;79(3):362-73.

PMID:
7957756
14.

The liver stage of Plasmodium berghei inhibits host cell apoptosis.

van de Sand C, Horstmann S, Schmidt A, Sturm A, Bolte S, Krueger A, Lütgehetmann M, Pollok JM, Libert C, Heussler VT.

Mol Microbiol. 2005 Nov;58(3):731-42.

PMID:
16238623
15.

[Plasmodium sporozoite entry pathways during malaria liver infection].

Risco-Castillo V, Son O, Franetich JF, Rubinstein E, Mazier D, Silvie O.

Biol Aujourdhui. 2013;207(4):219-29. doi: 10.1051/jbio/2013021. Epub 2014 Mar 5. French.

PMID:
24594570
16.

In vitro alterations do not reflect a requirement for host cell cycle progression during Plasmodium liver stage infection.

Hanson KK, March S, Ng S, Bhatia SN, Mota MM.

Eukaryot Cell. 2015 Jan;14(1):96-103. doi: 10.1128/EC.00166-14. Epub 2014 Nov 21.

PMID:
25416236
17.

A cysteine protease inhibitor of plasmodium berghei is essential for exo-erythrocytic development.

Lehmann C, Heitmann A, Mishra S, Burda PC, Singer M, Prado M, Niklaus L, Lacroix C, Ménard R, Frischknecht F, Stanway R, Sinnis P, Heussler V.

PLoS Pathog. 2014 Aug 28;10(8):e1004336. doi: 10.1371/journal.ppat.1004336. eCollection 2014 Aug.

PMID:
25166051
18.

Malaria sporozoite: migrating for a living.

Silvie O, Franetich JF, Rénia L, Mazier D.

Trends Mol Med. 2004 Mar;10(3):97-100; discussion 100-1. Review.

PMID:
15106591
19.
20.

Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection.

Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, Moreau M, Collet X, Siau A, van Gemert GJ, Sauerwein RW, Luty AJ, Vaillant JC, Hannoun L, Chapman J, Mazier D, Froissard P.

Cell Host Microbe. 2008 Sep 11;4(3):283-92. doi: 10.1016/j.chom.2008.07.013.

PMID:
18779054

Supplemental Content

Support Center